查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600930

人类增强市场：按类型、功能、最终用途划分 - 2025-2030 年全球预测

Human Augmentation Market by Type (Augmented Reality Device, Biometric System, Exoskeletons), Functionality (Body Worn, Non-Body Worn), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人类增强市场的市场规模为2,558.4亿美元，预计2024年将达到2,962.4亿美元，复合年增长率为15.96%，到2030年将达到7,214.4亿美元。

人类增强是指用于改善人类身体或认知方面的表现或表现的技术和技巧。广泛的应用包括穿戴式装置、外骨骼、脑机介面、基因增强等。该领域的驱动力是提高人类效率、健康和生活品质的需求，特别是在残疾、医疗保健和劳动生产力领域。由于提高身体表现和决策能力的潜在好处，医疗保健和军事领域是重要的最终用途领域。人类增强市场受到人工智慧、物联网和奈米技术等技术进步的影响，为个人化医疗、增强学习环境和需要精确人机介面的产业创造了机会。科技巨头投资的增加以及老年护理辅助设备需求的增加进一步提振了市场。然而，该领域面临挑战，包括道德问题、开发和实施的高成本以及可能减缓创新的严格法规结构。主要限制包括滥用技术的可能性和隐私问题，特别是在脑机介面方面。创新可以来自开发更实惠的穿戴式装置和改进使用者介面系统。关于增强人工智慧更自然、更有效地解释人类输入的能力的研究正在蓬勃发展。透过专注于与医疗机构的联合计划，公司可以更好地将医疗需求和患者准备与技术进步结合起来。还有潜力探索人类增强，透过认知增强工具来提高创新产业和工人生产力。市场主要是创新主导的，是一个动态的格局，需要不断适应新兴技术、道德指南和消费者接受趋势。透过专注于道德发展、成本效益和以使用者为中心的设计，公司可以最大限度地发挥人类增强的潜力，同时降低风险。

主要市场统计
基准年[2023] 2558.4亿美元
预测年份 [2024] 2962.4亿美元
预测年份 [2030] 7214.4亿美元
复合年增长率（%） 15.96%

市场动态：揭示快速发展的人类增强市场的关键市场洞察

供需的动态交互作用正在改变人类增强市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 提高认知和身体增强应用的意识和接受度
    • 医疗穿戴式装置对人类增强的需求不断增长
    • 航太和国防对手势追踪的需求不断增长
  • 市场限制因素
    • 开发人类增强技术成本高
  • 市场机会
    • 不断介绍技术先进的人类增强
    • 政府支持与私人投资开发人类增强技术
  • 市场挑战
    • 由于人类增强技术的使用而导致资料外洩和个人资讯外洩的风险

波特的五力：驾驭人类增强市场的策略工具

波特的五力框架是了解人类增强市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解人类增强市场的外部影响

外部宏观环境因素在塑造人类增强市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人类增强市场的竞争状况

对人类增强市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵人类增强市场供应商绩效评估

FPNV 定位矩阵是评估人类增强市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的广泛资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高人们对可增强认知和身体表现的应用程式的认识和接受度
      • 医疗穿戴式装置对人类增强的需求不断增长
      • 航太和国防领域对手势追踪的需求不断增长
    • 抑制因素
      • 开发人类增强技术的成本很高。
    • 机会
      • 不断介绍技术先进的人类增强
      • 政府对技术开发的支持与私人投资
    • 任务
      • 由于使用人类增强技术而存在资料和个人资讯外洩的风险
  • 市场区隔分析
    • 类型：扩大扩增扩增实境设备的使用，提供免持资料存取和导航指导
    • 功能：更多使用穿戴式人类增强来提高活动能力和耐力
    • 最终用户：扩大人类增强技术在製造业的应用，以提高工人的生产力和效率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人类增强市场：依类型

  • 扩增实境设备
  • 生物识别系统
  • 外骨骼
  • 智慧虚拟助理
  • 虚拟实境设备
  • 穿戴式装置

第七章依功能分類的人类增强市场

  • 身体穿着
  • 非身体佩戴的

第八章人类增强市场：依最终用途分类

  • 航太和国防
  • 卫生保健
  • 製造业
  • 媒体与娱乐

第九章美洲人类增强市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区人类增强市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的人类增强市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Google和高通合作开发用于穿戴式装置的 RISC-V 晶片
    • Vuzix 与广达电脑签署合作协议
    • Humane正式推出基于OpenAI的可穿戴设备“AI Pin”
    • 实现人与人之间的连结：Phantom Neuro 结合了人类增强和物联网
    • 由 SFU 研究人员开发的 XoMotion 成为世界上最先进的外骨骼，适用于行动不便的人
    • 杜邦与意法半导体 (ST) 合作开发用于监测生物讯号的新型智慧穿戴装置概念
    • 穿戴式装置公司 Oura 收购数位身分Start-UpsProxy
    • 200 万欧元资金用于新型人类增强创新，以增强人类的防御能力
    • ARIA Research 获得 140 万美元津贴，在雪梨建立人类增强研究所
    • Ekso Bionics 宣布从 Parker Hannifin 公司收购人体运动与控制业务部门，包括 Indego 产品线
    • 京瓷在日本推出新的人类增强技术原型，配备先进的人工智慧以增强人类能力
    • Dasa 推出新的创新重点领域：人类增强(HA)
    • 巴黎Start-Ups筹集 4500 万美元用于开发人类体外骨骼

公司名单

  • 3M Company
  • Amazon.com, Inc.
  • Apple Inc.
  • AppliedVR, Inc.
  • Aptima, Inc.
  • Atheer, Inc.
  • B-Temia Inc.
  • Charles River Analytics, Inc.
  • Cionic, Inc.
  • Cognitive Mill by AIHunters
  • Continental AG
  • CYBERDYNE Inc.
  • Ekso Bionics Holdings, Inc.
  • Esper Bionics Inc.
  • Fujitsu Limited
  • Garmin Limited
  • General Motors Company
  • Google LLC by Alphabet, Inc.
  • HID Global Corporation by Assa Abloy AB
  • Hocoma AG by DIH International Limited
  • HTC Corporation
  • Hyundai Motor Company
  • IDEMIA Group, SAS
  • Kyocera Corporation
  • Lifesense Group
  • Magic Leap Inc.
  • Meta Platforms, Inc.
  • Microsoft Corporation
  • NEC Corporation
  • Nvidia Corporation
  • Ottobock SE & Co. KGaA
  • Panasonic Corporation
  • Parker Hannifin Corporation
  • Rewalk Robotics Inc.
  • Rex Bionics Ltd
  • Robert Bosch GmbH
  • RTX Corporation
  • Saab AB
  • Samsung Electronics Co., Ltd.
  • Soar Technology, Inc.
  • Sony Group Corporation
  • Thales Group
  • Unity Software Inc.
  • Vuzix Corporation
Product Code: MRR-0355904475EC

The Human Augmentation Market was valued at USD 255.84 billion in 2023, expected to reach USD 296.24 billion in 2024, and is projected to grow at a CAGR of 15.96%, to USD 721.44 billion by 2030.

Human augmentation refers to the techniques and technologies used to enhance human capabilities and performance physically or cognitively. It encompasses a wide array of applications such as wearable gadgets, exoskeletons, brain-machine interfaces, and genetic enhancements. This field is driven by the necessity to improve human efficiency, health, and quality of life, especially in areas of disability, healthcare, and workforce productivity. Healthcare and military sectors represent significant end-use scopes due to the potential benefits of enhanced physical performance and decision-making capabilities. The market for human augmentation is influenced by advancements in technologies like AI, IoT, and nanotechnology, creating opportunities in personalized medicine, enhanced learning environments, and industries requiring precise human-machine interfaces. Growing investments from tech giants and the increasing demand for assistive devices in elder care further propel the market. However, this sector faces challenges such as ethical concerns, high costs of development and implementation, and stringent regulatory frameworks that may slow innovation. Key limitations include the potential for misuse of technology and privacy concerns, particularly with brain-machine interfaces. Innovations are likely in the development of more affordable wearable devices and improved user interface systems. Research is booming in enhancing AI capabilities to interpret human inputs more naturally and efficiently. Businesses could focus on collaborative projects with medical institutions to better align technological advancements with healthcare needs and patient acceptance. Additionally, there is potential to explore human augmentation in enhancing creative industries and workforce productivity through cognitive enhancement tools. The market is predominantly innovation-driven, with a dynamic landscape that requires constant adaptation to emerging technologies, ethical guidelines, and consumer acceptance trends. By focusing on ethical development, cost-effectiveness, and user-centric designs, businesses can harness the full potential of human augmentation while mitigating risks.

KEY MARKET STATISTICS
Base Year [2023] USD 255.84 billion
Estimated Year [2024] USD 296.24 billion
Forecast Year [2030] USD 721.44 billion
CAGR (%) 15.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Augmentation Market

The Human Augmentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness and acceptance of cognitive and physical enhancement applications
    • Rising need for human augmentation for medical wearable devices
    • Increasing demand from aerospace & defense for gesture-tracking purposes
  • Market Restraints
    • High cost of development of human augmentation technologies
  • Market Opportunities
    • Continuous introduction of technologically advanced human augmentation
    • Government support and private investments for advancing human augmentation technologies
  • Market Challenges
    • Risk of data and identity breach with the usage of human augmentation technologies

Porter's Five Forces: A Strategic Tool for Navigating the Human Augmentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Augmentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Augmentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Augmentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Augmentation Market

A detailed market share analysis in the Human Augmentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Augmentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Augmentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Augmented Reality Device, Biometric System, Exoskeletons, Intelligent Virtual Assistants, Virtual Reality Device, and Wearable Device.
  • Based on Functionality, market is studied across Body Worn and Non-Body Worn.
  • Based on End-use, market is studied across Aerospace & Defense, Healthcare, Manufacturing, and Media & Entertainment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
      • 5.1.1.2. Rising need for human augmentation for medical wearable devices
      • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of human augmentation technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
      • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
    • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
    • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Augmentation Market, by Type

  • 6.1. Introduction
  • 6.2. Augmented Reality Device
  • 6.3. Biometric System
  • 6.4. Exoskeletons
  • 6.5. Intelligent Virtual Assistants
  • 6.6. Virtual Reality Device
  • 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

  • 7.1. Introduction
  • 7.2. Body Worn
  • 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

  • 8.1. Introduction
  • 8.2. Aerospace & Defense
  • 8.3. Healthcare
  • 8.4. Manufacturing
  • 8.5. Media & Entertainment

9. Americas Human Augmentation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Augmentation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
    • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
    • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
    • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
    • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
    • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
    • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
    • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
    • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
    • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
    • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
    • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
    • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

Companies Mentioned

  • 1. 3M Company
  • 2. Amazon.com, Inc.
  • 3. Apple Inc.
  • 4. AppliedVR, Inc.
  • 5. Aptima, Inc.
  • 6. Atheer, Inc.
  • 7. B-Temia Inc.
  • 8. Charles River Analytics, Inc.
  • 9. Cionic, Inc.
  • 10. Cognitive Mill by AIHunters
  • 11. Continental AG
  • 12. CYBERDYNE Inc.
  • 13. Ekso Bionics Holdings, Inc.
  • 14. Esper Bionics Inc.
  • 15. Fujitsu Limited
  • 16. Garmin Limited
  • 17. General Motors Company
  • 18. Google LLC by Alphabet, Inc.
  • 19. HID Global Corporation by Assa Abloy AB
  • 20. Hocoma AG by DIH International Limited
  • 21. HTC Corporation
  • 22. Hyundai Motor Company
  • 23. IDEMIA Group, S.A.S.
  • 24. Kyocera Corporation
  • 25. Lifesense Group
  • 26. Magic Leap Inc.
  • 27. Meta Platforms, Inc.
  • 28. Microsoft Corporation
  • 29. NEC Corporation
  • 30. Nvidia Corporation
  • 31. Ottobock SE & Co. KGaA
  • 32. Panasonic Corporation
  • 33. Parker Hannifin Corporation
  • 34. Rewalk Robotics Inc.
  • 35. Rex Bionics Ltd
  • 36. Robert Bosch GmbH
  • 37. RTX Corporation
  • 38. Saab AB
  • 39. Samsung Electronics Co., Ltd.
  • 40. Soar Technology, Inc.
  • 41. Sony Group Corporation
  • 42. Thales Group
  • 43. Unity Software Inc.
  • 44. Vuzix Corporation

LIST OF FIGURES

  • FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN AUGMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023